Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity

Cellmid Limited

ABN

69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Ms Maria Halasz

Date of last notice

13 September 2018

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Indirect

Nature of indirect interest (including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Direct Capital Group Pty Ltd and Direct Capital Pty Ltd - Entities controlled by the Director

Date of change

13 November 2018, 12 November 2018 and 30 October 2018

No. of securities held prior to change

Direct 420,000 fully paid ordinary shares 400,000 fully paid ordinary (loan) shares

Indirect 1,016,808 fully paid ordinary shares

Class

Fully paid ordinary shares

Number acquired

522,130

Number disposed

Nil

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

22,130 at $0.35 per share (total value of $7,745.50)

500,000 at deemed issue price of $0.37 per share

No. of securities held after change

Direct 420,000 fully paid ordinary shares 400,000 fully paid ordinary (loan) shares

Indirect 1,538,938 fully paid ordinary shares

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

22,130 through on market trades

500,000 issued in consideration of FY2018 performance, as approved at the Company's 2018 AGM held on 8 November 2018

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder (if issued securities)

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

N/A

Interest after change

N/A

Part 3 - +Closed period

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Attachments

Disclaimer

Cellmid Limited published this content on 13 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 November 2018 03:33:02 UTC